A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan
详细信息 查看全文
- 作者：Lung-Sheng Wu ; Shang-Hung Chang ; Gwo-Jyh Chang ; Jia-Rou Liu…
- 关键词：Angiotensin converting enzyme inhibitors ; Angiotensin receptor blockers ; Diabetes mellitus ; Major adverse cardiovascular events ; End ; stage renal disease
- 刊名：Cardiovascular Diabetology
- 出版年：2016
- 出版时间：December 2016
- 年：2016
- 卷：15
- 期：1
- 全文大小：909 KB
- 刊物主题：Diabetes; Angiology; Cardiology;
- 出版者：BioMed Central
- ISSN：1475-2840
文摘
Background Contemporary guidelines recommend angiotensin-converting-enzyme inhibitors (ACEi) or angiotensin-receptor blockers (ARB) for hypertensive patients with diabetes. However, there is limited data to evaluate the comparison between ACEi and ARB on end stage renal disease (ESRD) and major adverse cardiovascular events (MACE), in Asian diabetic patients.